The Phase III Clinical Trial Launch Meeting for Beletalent’s Tangning Tongluo Tablets was successfully held
The Phase III Clinical Trial Launch Meeting of Tangning Tongluo Tablets On January 18, the Phase III clinical trial launch […]
The Phase III Clinical Trial Launch Meeting of Tangning Tongluo Tablets On January 18, the Phase III clinical trial launch […]
Case of “Tangning Tongluo Tablets” Exempted from Phase II Clinical Trials Shared On November 21, 2024, the 15th special report
Tangning Tongluo Tablets Approved to Directly Conduct Phase III Clinical Trials On November 12, Beletalent (ZHUHAI) Pharmaceutical Co., Ltd.(hereinafter referred to as Beletalent) received
Beletalent Deepens Exchange with Portuguese-speaking Countries Traditional Medicine Seminar Promote Innovation and Development in the Pharmaceutical Field Recently, the
Guizhou Bailing & MACAO G-RX made a splendid appearance at the International Exhibition on Healthcare, Education, and Sports Opens in Ashgabat
Achievements in the field of innovation of new Chinese medicines From September 7th to 9th, the 2024 Healthy China (Hengqin)
Yindan Xinnaotong Soft Capsules Obtained The Registration And Marketing Authorization For Traditional Chinese Medicine In Brazil. Recently, the overseas registration
MACAO G-RX CO., LTD. On July 9, Beletalent’s subsidiary”MACAO G-RX CO., LTD.“was successfully registered in Macao, and its business scope
As one of the settled enterprises in the Traditional Chinese Medicine Science and Technology Industrial Park of Co-operation between Guangdong
THE FIRST FACE TO FACE COMMUNICATION GUIDANCE MEETING WITH THE GUANGDONG-HONG KONG-MACAO GREATER BAY AREA CENTER FOR DRUG EVALUATION AND